{"pmid":32234728,"title":"EMA advice on the use of NSAIDs for Covid-19.","text":["EMA advice on the use of NSAIDs for Covid-19.","Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.","Drug Ther Bull","32234728"],"abstract":["Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned."],"journal":"Drug Ther Bull","date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234728","week":"202014|Mar 30 - Apr 05","doi":"10.1136/dtb.2020.000021","keywords":["Health Care Quality, Access, and Evaluation","Primary Health Care"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662996001883947008,"score":7.6048946,"similar":[{"pmid":32228860,"title":"SARS-CoV-2 (COVID-19) by the numbers.","text":["SARS-CoV-2 (COVID-19) by the numbers.","The current SARS-CoV-2 pandemic is a harsh reminder of the fact that, whether in a single human host or a wave of infection across continents, viral dynamics is often a story about the numbers. In this snapshot, our aim is to provide a one-stop, curated graphical source for the key numbers that help us understand the virus driving our current global crisis. The discussion is framed around two broad themes: 1) the biology of the virus itself and 2) the characteristics of the infection of a single human host. Our one-page summary provides the key numbers pertaining to SARS-CoV-2, based mostly on peer-reviewed literature. The numbers reported in summary format are substantiated by the annotated references below. Readers are urged to remember that much uncertainty remains and knowledge of this pandemic and the virus driving it is rapidly evolving. In the paragraphs below we provide 'back of the envelope' calculations that exemplify the insights that can be gained from knowing some key numbers and using quantitative logic. These calculations serve to improve our intuition through sanity checks, but do not replace detailed epidemiological analysis.","Elife","Bar-On, Yinon M","Flamholz, Avi","Phillips, Rob","Milo, Ron","32228860"],"abstract":["The current SARS-CoV-2 pandemic is a harsh reminder of the fact that, whether in a single human host or a wave of infection across continents, viral dynamics is often a story about the numbers. In this snapshot, our aim is to provide a one-stop, curated graphical source for the key numbers that help us understand the virus driving our current global crisis. The discussion is framed around two broad themes: 1) the biology of the virus itself and 2) the characteristics of the infection of a single human host. Our one-page summary provides the key numbers pertaining to SARS-CoV-2, based mostly on peer-reviewed literature. The numbers reported in summary format are substantiated by the annotated references below. Readers are urged to remember that much uncertainty remains and knowledge of this pandemic and the virus driving it is rapidly evolving. In the paragraphs below we provide 'back of the envelope' calculations that exemplify the insights that can be gained from knowing some key numbers and using quantitative logic. These calculations serve to improve our intuition through sanity checks, but do not replace detailed epidemiological analysis."],"journal":"Elife","authors":["Bar-On, Yinon M","Flamholz, Avi","Phillips, Rob","Milo, Ron"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228860","week":"202014|Mar 30 - Apr 05","doi":"10.7554/eLife.57309","keywords":["epidemiology","global health","human","infectious disease","microbiology"],"source":"PubMed","topics":["General Info"],"weight":1,"_version_":1662899337766633474,"score":89.593506},{"pmid":32233560,"title":"COVID-19 information propagation dynamics in the Chinese Sina-microblog.","text":["COVID-19 information propagation dynamics in the Chinese Sina-microblog.","The outbreak of a novel coronavirus (COVID-19) generated an outbreak of public opinions in the Chinese Sina-microblog. To help in designing effective communication strategies during a major public health emergency, we propose a multiple-information susceptible-discussing-immune (M-SDI) model in order to understand the patterns of key information propagation on social networks. We develop the M-SDI model, based on the public discussion quantity and take into account of the behavior that users may re-enter another related topic or Weibo after discussing one. Data fitting using the real data of COVID-19 public opinion obtained from Chinese Sina-microblog can parameterize the model to make accurate prediction of the public opinion trend until the next major news item occurs. The reproduction ratio has fallen from 1.7769 and maintained around 0.97, which reflects the peak of public opinion has passed but it will continue for a period of time.","Math Biosci Eng","Yin, Fu Lian","Lv, Jia Hui","Zhang, Xiao Jian","Xia, Xin Yu","Wu, Jian Hong","32233560"],"abstract":["The outbreak of a novel coronavirus (COVID-19) generated an outbreak of public opinions in the Chinese Sina-microblog. To help in designing effective communication strategies during a major public health emergency, we propose a multiple-information susceptible-discussing-immune (M-SDI) model in order to understand the patterns of key information propagation on social networks. We develop the M-SDI model, based on the public discussion quantity and take into account of the behavior that users may re-enter another related topic or Weibo after discussing one. Data fitting using the real data of COVID-19 public opinion obtained from Chinese Sina-microblog can parameterize the model to make accurate prediction of the public opinion trend until the next major news item occurs. The reproduction ratio has fallen from 1.7769 and maintained around 0.97, which reflects the peak of public opinion has passed but it will continue for a period of time."],"journal":"Math Biosci Eng","authors":["Yin, Fu Lian","Lv, Jia Hui","Zhang, Xiao Jian","Xia, Xin Yu","Wu, Jian Hong"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32233560","week":"202014|Mar 30 - Apr 05","doi":"10.3934/mbe.2020146","keywords":["COVID-19","Sina-microblog","dynamic model","prediction"],"source":"PubMed","locations":["Chinese","Weibo"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1662996001794818048,"score":81.10812},{"pmid":32230900,"title":"Virology, Epidemiology, Pathogenesis, and Control of COVID-19.","text":["Virology, Epidemiology, Pathogenesis, and Control of COVID-19.","The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.","Viruses","Jin, Yuefei","Yang, Haiyan","Ji, Wangquan","Wu, Weidong","Chen, Shuaiyin","Zhang, Weiguo","Duan, Guangcai","32230900"],"abstract":["The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review."],"journal":"Viruses","authors":["Jin, Yuefei","Yang, Haiyan","Ji, Wangquan","Wu, Weidong","Chen, Shuaiyin","Zhang, Weiguo","Duan, Guangcai"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32230900","week":"202014|Mar 30 - Apr 05","doi":"10.3390/v12040372","keywords":["COVID-19","SARS-CoV-2","epidemiology","pathogenesis","therapeutics"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Transmission","Treatment"],"weight":1,"_version_":1662899337673310209,"score":78.9876},{"pmid":32196406,"title":"COVID-19 (Coronavirus).","text":["COVID-19 (Coronavirus).","This strain of coronavirus is a new one and scientists do not yet know all there is to know about it. While these common sense points will always be helpful, it is important that you keep up to date with the advice being given by the Centers for Disease Control and Prevention (CDC) and NHS England and how it might affect you personally. These suggestions have been produced using the most up-to-date advice available to us from our Scientific and Medical Advisors and are not intended to replace or supersede advice you may have been given from your health care professional.","Lymphat Res Biol","32196406"],"abstract":["This strain of coronavirus is a new one and scientists do not yet know all there is to know about it. While these common sense points will always be helpful, it is important that you keep up to date with the advice being given by the Centers for Disease Control and Prevention (CDC) and NHS England and how it might affect you personally. These suggestions have been produced using the most up-to-date advice available to us from our Scientific and Medical Advisors and are not intended to replace or supersede advice you may have been given from your health care professional."],"journal":"Lymphat Res Biol","date":"2020-03-21T11:00:00Z","year":2020,"_id":"32196406","week":"202012|Mar 16 - Mar 22","doi":"10.1089/lrb.2020.29084.cov","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662334543197110272,"score":77.9497},{"pmid":32195698,"title":"COVID-19 Infection: Implications for Perioperative and Critical Care Physicians.","text":["COVID-19 Infection: Implications for Perioperative and Critical Care Physicians.","Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or mild illness to hypoxemic respiratory failure or multisystem organ failure, necessitating intubation and intensive care management. Healthcare providers, and particularly anesthesiologists, are at the frontline of this epidemic, and they need to be aware of the best available evidence to guide therapeutic management of patients with COVID-19 and to keep themselves safe while doing so. Here, the authors review COVID-19 pathogenesis, presentation, diagnosis, and potential therapeutics, with a focus on management of COVID-19-associated respiratory failure. The authors draw on literature from other viral epidemics, treatment of acute respiratory distress syndrome, and recent publications on COVID-19, as well as guidelines from major health organizations. This review provides a comprehensive summary of the evidence currently available to guide management of critically ill patients with COVID-19.","Anesthesiology","Greenland, John R","Michelow, Marilyn D","Wang, Linlin","London, Martin J","32195698"],"abstract":["Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or mild illness to hypoxemic respiratory failure or multisystem organ failure, necessitating intubation and intensive care management. Healthcare providers, and particularly anesthesiologists, are at the frontline of this epidemic, and they need to be aware of the best available evidence to guide therapeutic management of patients with COVID-19 and to keep themselves safe while doing so. Here, the authors review COVID-19 pathogenesis, presentation, diagnosis, and potential therapeutics, with a focus on management of COVID-19-associated respiratory failure. The authors draw on literature from other viral epidemics, treatment of acute respiratory distress syndrome, and recent publications on COVID-19, as well as guidelines from major health organizations. This review provides a comprehensive summary of the evidence currently available to guide management of critically ill patients with COVID-19."],"journal":"Anesthesiology","authors":["Greenland, John R","Michelow, Marilyn D","Wang, Linlin","London, Martin J"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32195698","week":"202012|Mar 16 - Mar 22","doi":"10.1097/ALN.0000000000003303","source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663095625897476096,"score":74.2102}]}